The Exposure Most Small Cap Founders Overlook

Most founders who take their company public on OTC markets, complete a Regulation A+ offering, or raise a Regulation D round believe they are operating well below the radar of serious securities litigation. They are wrong. And the mistake is an expensive one.

Securities claims are not reserved for companies trading on the NYSE with a $10 billion float. California securities law reaches private companies, early-stage public companies, and any company that raised money from investors through written materials that turned out to be incomplete or misleading. The size of the company determines the size of the damages sought. It does not determine whether a claim exists.

California has its own securities statute, the Corporate Securities Law of 1968, which operates alongside federal securities law and sometimes provides plaintiffs with more favorable recovery standards. Companies operating here face exposure on two fronts simultaneously. That is a structural fact of doing business in this state, and it is one that most outside counsel hired for a funding round never explains clearly to the founders they serve.

---

What Securities Litigation Actually Looks Like at This Scale

Before you can recognize your exposure, you need a clear picture of what these cases actually involve. There are four main vehicles.

Shareholder class actions. One investor files on behalf of all similarly situated investors. These are rare at the small cap level but not unheard of, particularly after a significant stock drop following a disclosure.

Individual shareholder suits. A single investor, often someone who put in $500,000 or more in a Regulation D round, claims they were induced to invest through materially false or misleading statements. These cases do not require a class. One angry investor with a competent attorney is enough to trigger a full federal or state securities proceeding.

Derivative claims. Here the shareholder sues on behalf of the company, typically against directors or officers who allegedly breached their fiduciary duties. The company is technically the plaintiff, even though shareholders are driving the case. These are common when a small cap board approves a related-party transaction that enriches insiders at the expense of other shareholders.

Breach of fiduciary duty as a standalone claim. Directors and officers of California companies owe duties of care and loyalty to shareholders. When a board decision damages shareholders and the process behind that decision was flawed, a fiduciary duty claim can stand on its own, without any securities fraud allegation attached to it.

The distinction between these theories matters a great deal, because the defenses, procedural posture, and discovery obligations differ significantly across them. A company that conflates them when deciding how to respond is already behind.

---

The Four Warning Signs Your Company Is Already Exposed

1. Materially misleading statements in investor materials. This is the most common trigger. A pitch deck, an offering memorandum, or a quarterly investor letter that overstated revenue projections, understated known risks, or omitted a material fact can form the basis of a securities claim. "Material" is a legal standard, not a judgment call, and courts apply it broadly. If a reasonable investor would have wanted to know the fact before investing, omitting it creates exposure.

2. Undisclosed insider transactions. A founder who sold shares to a new investor while simultaneously selling shares on a secondary market, without disclosing that, has a real problem. So does a company whose CEO received compensation from a counterparty in a transaction the company was also a party to. These scenarios generate both regulatory attention and private litigation.

3. A shareholder dilution event or freeze-out that lacked full board process. Issuing shares in a down round that wiped out early investors, or restructuring equity to concentrate control among founders, can constitute a breach of fiduciary duty to minority shareholders. The board process surrounding that decision matters enormously. Board minutes, independent committee review, and the presence of a fairness opinion can determine whether the company survives the litigation. Their absence can determine that it does not.

4. A departing employee who took financial projections or investor information. This one surprises clients. An employee who leaves and takes confidential financial models, investor lists, or non-public company projections is not just a trade secret misappropriation problem. If that person uses the information to trade in the company's securities or to assist a competitor in raising capital, the company faces a potential securities angle as well. The lines between IP litigation and securities litigation blur quickly when financial information is involved.

---

Private Companies Are Not Safe Harbor

This is the assumption that causes the most damage. Private companies in California raise money under Regulation D exemptions every day. They send investor updates. They make representations in side letters. They negotiate co-investment rights with major investors. Every one of those communications can create securities exposure.

A minority shareholder in a private California company who believes they were misled about the company's financial condition when they invested has legal options. They can assert claims under California Corporations Code as well as under federal securities law in certain circumstances. A down round that reduces their equity to near-zero while insiders receive preferential treatment is precisely the scenario that generates these suits.

Failed acquisitions are another trigger. If a company was in acquisition discussions and issued shares, or if management made representations to investors about the likelihood of an exit that did not materialize, those representations get scrutinized after the fact.

The exposure is real. The suits do get filed. And they arrive at moments when the company is already under financial stress, which makes them particularly destructive. Having breach of contract litigation counsel on speed dial helps, but securities disputes require practitioners who know both the federal private securities fraud standards and California's state law overlay.

---

How California Courts Treat These Disputes

California state courts and federal district courts in the Central and Southern Districts handle securities cases differently, and the choice of forum is not always the plaintiff's to make. The Private Securities Litigation Reform Act of 1995 governs federal securities fraud class actions and imposes specific pleading requirements that make early dismissal more achievable for defendants. California state law claims do not carry those same procedural protections.

That asymmetry matters. A plaintiff who files a claim under California law instead of federal law can sometimes avoid the heightened pleading standard, making it harder for defendants to get the case dismissed early. The practical consequence: companies defending securities claims in California state court often face more extensive and more expensive discovery before they get a ruling on whether the claim is legally sufficient.

What does work as a defense, generally speaking: showing that the statements at issue were not material, that the investor did not actually rely on the statements, or that the company's disclosures were complete given what management knew at the time. Subjective good faith is not a defense in all contexts, but demonstrating a genuine, well-documented decision-making process goes a long way.

What does not work: asserting that the company was small, that the investors were sophisticated, or that the deal closed so the investors should have done more diligence. Courts do not accept these as complete defenses, and juries are even less receptive.

One often-overlooked tool at the board level is independent director representation during an internal investigation. When a securities complaint arrives, or when a regulatory inquiry begins, the board's independent directors may have interests distinct from those of management. Separate representation for those directors is not only appropriate, it is often essential to establishing a good-faith defense to the underlying claims.

---

How Thomas Whitelaw Approaches Securities Litigation for Smaller Companies

Thomas Whitelaw & Kolegraff LLP was founded in 2000 by trial lawyers who left large international firms specifically to build a boutique where partners, not associates, run the cases. The partners on your matter have between 15 and 35 years of litigation experience. They know the documents. They are in the room.

For small cap and private companies, that structure is particularly important. Securities litigation requires judgment calls at every stage: which claims to challenge on a motion to dismiss, which witnesses to depose first, whether an early mediation serves the company's interests or simply extends its distraction. Those judgment calls need to come from someone with real trial experience, not someone who graduated three years ago.

The firm handled a $33 million judgment for a shopping center owner in an inverse condemnation dispute, the largest judgment in San Mateo County at the time. It secured a $102 million payment to landowners in a quiet title and inverse condemnation matter. It took over the defense of a $10 million patent infringement case, Whitewater West Industries, Ltd. v. Pacific Surf Designs, Inc. (S.D. Cal. No. 3:17-cv-01118), about 30 days before trial, and the jury found no infringement. Prior results do not guarantee a similar outcome; every case depends on its own facts.

The firm also took a similar approach to patent litigation for companies without large legal budgets, which gives some context for how alternative fee arrangements work in high-stakes matters. For securities cases, the firm offers hourly, fixed, project-based, and success fee structures, alone or in combination. Open-ended billing that runs for years is not the only option. If your claim is strong but your legal budget is not, that conversation is worth having.

Thomas Whitelaw & Kolegraff LLP is located at 18101 Von Karman Avenue, Suite 230, Irvine, CA 92612. Reach the firm at (949) 679-6400 or info@thomas-whitelaw.com. This post is for general information only and is not legal advice.

Securities litigation moves on a timeline that does not wait for a company to get organized. The warning signs described here are patterns we see repeatedly. If any of them are present in your company's current situation, the right moment to get counsel involved is before the complaint arrives, not after.